Bausch Health Companies Inc (BHC)

Bausch Health Companies Inc. is a common equity listing on the NYSE for a diversified specialty pharmaceutical and medical device company. Through its operating segments Salix, International, Solta Medical, Diversified, and Bausch + Lomb, the company develops, manufactures, and markets products across gastroenterology, hepatology, neurology, dermatology, generic pharmaceuticals, over-the-counter products, aesthetic medical devices, and eye health. Its business has operations in the United States and in international markets. Salix focuses on gastroenterology products, while International sells aesthetic medical devices, branded and generic pharmaceuticals, and OTC products. Solta Medical is centered on aesthetic medical devices, the Diversified segment includes products for neurology, dermatology, generic pharmaceuticals, and dentistry, and Bausch + Lomb covers vision care, surgical, and pharmaceutical products. The company was previously known as Valeant Pharmaceuticals International, Inc. and adopted its current name in July 2018. It is headquartered in Laval, Canada.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.